Oasmia Pharmaceutical AB ADR | 424B3: Prospectus
Apr 5, 2022 00:04
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 16, 2019 04:05
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 20, 2019 07:14
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 1, 2018 06:51
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 1, 2018 08:23
Oasmia Pharmaceutical AB ADR | 20-F: FY2018 Annual Report
Sep 15, 2018 04:07
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
May 23, 2018 05:11
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
May 14, 2018 22:24
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
May 4, 2018 03:22
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
Mar 29, 2018 02:57
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 7, 2018 05:10
Oasmia Pharmaceutical AB ADR | CORRESP: CORRESP
Feb 24, 2018 00:40
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 21, 2018 20:19
Oasmia Pharmaceutical AB ADR | UPLOAD: Others
Feb 15, 2018 07:21
Oasmia Pharmaceutical AB ADR | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Feb 14, 2018 22:39
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 26, 2018 05:05
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 3, 2018 05:06
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 13, 2017 05:15
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 7, 2017 07:05
Oasmia Pharmaceutical AB ADR | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 7, 2017 07:04
No Data
No Data